ECTRIMS Postdoctoral Research Fellowship Exchange Programme

Overview

To be eligible for the ECTRIMS Postdoctoral Research Fellowship, applicants must possess an MD, PhD, or equivalent degree in the relevant field. The programme is open to candidates of any nationality who are willing to undertake postdoctoral research in Multiple Sclerosis. Applicants should demonstrate significant academic achievements and a strong commitment to research within the realm of neuroscience. Additionally, candidates are expected to collaborate with a mentor and host training institute, which must be different from their current workplace. Other requirements include submission of relevant documents and evidence of professional referees to support their application.

About the Scholarship

The ECTRIMS Postdoctoral Research Fellowship Exchange Programme is designed for emerging neuroscientists dedicated to exploring the complexities of Multiple Sclerosis (MS). Funded by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), this fellowship supports postdoctoral researchers holding MD, PhD, or equivalent degrees. The fellowship enhances their training in various aspects of MS through a mentored research programme situated in renowned European laboratories or clinics. Aimed at building a strong community of researchers, this initiative prioritizes knowledge sharing, innovative research, and professional growth. Each fellowship lasts one to two years depending on the specifics of the candidate's research training.

Eligibility Criteria

To be eligible for the ECTRIMS Postdoctoral Research Fellowship, applicants must possess an MD, PhD, or equivalent degree in the relevant field. The programme is open to candidates of any nationality who are willing to undertake postdoctoral research in Multiple Sclerosis. Applicants should demonstrate significant academic achievements and a strong commitment to research within the realm of neuroscience. Additionally, candidates are expected to collaborate with a mentor and host training institute, which must be different from their current workplace. Other requirements include submission of relevant documents and evidence of professional referees to support their application.

Benefits and Financial Coverage

The ECTRIMS Postdoctoral Research Fellowship provides comprehensive financial coverage that includes a full stipend, healthcare benefits, and allowances necessary for successful completion of the research training. This funding is designed to facilitate the fellow's ability to focus entirely on their research and professional development without the burden of financial concerns. Ultimately, the support guarantees access to resources and a conducive environment for impactful research in Multiple Sclerosis.

How to Apply

Check eligibility criteria carefully. Prepare required documents, including application forms and reference letters. Create an account on the application portal. Fill in the application form with all necessary details. Submit your application before the deadline of 01 Dec, 2026.

Application Timeline and Deadlines

The application timeline for the ECTRIMS Postdoctoral Research Fellowship runs from 15 July to 01 December 2026. Applicants must ensure that their submissions are completed by the deadline to be considered for the fellowship.

Selection Process

The selection process involves a thorough review of applications by a panel of experts in the field of neuroscience and Multiple Sclerosis. Factors such as the applicant's research proposal, academic background, and recommendations will heavily influence the decision-making process. Successful candidates will be notified by April 2026.

FAQs

Students of any nationality holding an MD, PhD, or equivalent degree can apply.
The scholarship provides full funding, stipend, and healthcare benefits.
The application deadline is 01 Dec, 2026.
Research must be conducted in European laboratories or clinics.
The fellowship includes a stipend, healthcare benefits, and other allowances.
The duration of the fellowship is one to two years.
Only research related to Multiple Sclerosis is eligible.
Candidates will be informed of the decision by April 2026.